CLINICAL_TRIALS
research
· 2024-09-19
Clinical Trial Update: Magseed Pro(R)/ Sentimag(R) Gen3 [NA]
Summary
The trial update shows that a study evaluating Magseed Pro and Sentimag Gen3 for breast cancer is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endomagnetics Ltd. | Conditions: Breast Cancer | NA | Status: RECRUITING